Data on the individual problems and strengths scale from the systemic therapy inventory of change. Clinical samples from Norway
These data stem from 841 clients at different couple and family therapy sites in Norway that was collected between 2010 and 2016. They all answered the Individual Problems and Strengths scale (IPS) that is a part of the Systemic Therapy Inventory of Change (STIC) system in addition to some demograph...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/50035d313c7140598e5d89c0ab12c705 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | These data stem from 841 clients at different couple and family therapy sites in Norway that was collected between 2010 and 2016. They all answered the Individual Problems and Strengths scale (IPS) that is a part of the Systemic Therapy Inventory of Change (STIC) system in addition to some demographic variables. In addition to the 22 items constructing the IPS scale, the data contain 14 demographic variables describing age, educational level, civil status, prior therapeutic experience, use of medicine and year of data collection. Summary statistics are provided. Male and female clients between 12 and 72 years of age answered these questions prior to or at their first session of psychotherapy. The four sites collecting the data are located at different cities in the southern part of the country and represents low and high threshold agencies.The data can be used to test the construct validity of the measure for different populations. The data could, with a sample from the normal population, also be used for norming the scale and thus provide data to calculate cut off scores for clinical and non-clinical levels for each of the eight subscales. Further, the data could be used in combination with other measures of individual distress to test the construct validity of the scale within a Norwegian clinical sample and perhaps also within other countries. |
|---|